John Hiemenz is an Oncology physician affiliated with University of Florida. OpenAlex indexes 113 publications with 6,351 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1600 SW Archer Rd
Gainesville, FL 326103003
Telephone
352-273-7832Registry record last updated 2 Nov 2009.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Incyte CorporationProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
27.6%Thalidomide Analog20%Pomalyst100%Part D<11 patientsOther protein kinase inhibitors7.6%Xospata100%Part D<11 patientsNervous system
23.2%Opioid Agonist18%Tramadol Hcl42%Morphine Sulfate Er29%Oxycodone Hcl29%Part D<11 patientsGabapentinoids5.2%Gabapentin100%Part D<11 patientsAnti-infectives
21.2%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor15.6%Valacyclovir100%Part D≥11 patientsShort-acting sulfonamides5.6%Sulfamethoxazole-Trimethoprim100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A phase ib clinical trial of oral ciprofloxacin and etoposide in subjects with resistant acute myeloid leukemia
Leukemia & lymphoma/Leukemia and lymphoma
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Dekosky, MD
University of Florida
Brian Hoh, MD
University of Florida
Frederic Kaye, MD
University of Florida
Kelly Foote, MD
University of Florida
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”